BAXTER 0.225% SODIUM CHLORIDE and 3.75% GLUCOSE 500mL Injection BP AHB1243 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.225% sodium chloride and 3.75% glucose 500ml injection bp ahb1243

baxter healthcare pty ltd - glucose, quantity: 37.5 g/l; sodium chloride, quantity: 2.25 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.3% SODIUM CHLORIDE and 3.3% GLUCOSE 500mL injection AHB1033 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.3% sodium chloride and 3.3% glucose 500ml injection ahb1033

baxter healthcare pty ltd - glucose, quantity: 33 g/l; sodium chloride, quantity: 3 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.45% SODIUM CHLORIDE and 2.5% GLUCOSE 500mL injection AHB1023 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride and 2.5% glucose 500ml injection ahb1023

baxter healthcare pty ltd - glucose, quantity: 25 g/l; sodium chloride, quantity: 4.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 10% ANHYDROUS GLUCOSE 500mL injection AHB0163 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 10% anhydrous glucose 500ml injection ahb0163

baxter healthcare pty ltd - glucose, quantity: 100 g/l - injection, intravenous infusion - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

BAXTER 0.9% SODIUM CHLORIDE 450mg/50mL injection BP bag AHB1306/1363 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.9% sodium chloride 450mg/50ml injection bp bag ahb1306/1363

baxter healthcare pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid - indications as at 9 october 2002: sodium chloride (0.9%) intravenous infusion is indicated for extracellular fluid replacement and in the management of metabolic alkalosis in the presence of fluid loss, and for restoring or maintaining the concentration of sodium and chloride ions.

BAXTER 0.45% SODIUM CHLORIDE 2.25/500mL injection AHB1313 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride 2.25/500ml injection ahb1313

baxter healthcare pty ltd - sodium chloride, quantity: 4.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - indications as at 9 october 2002: hypotonic sodium chloride (0.45%) is mainly used as a hydrating agent solution.

BAXTER Chlorhexidine 0.1% Cetrimide 1% Solution AHF7978/7972/7986 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter chlorhexidine 0.1% cetrimide 1% solution ahf7978/7972/7986

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 1 mg/ml; cetrimide, quantity: 10 mg/ml - solution, irrigation - excipient ingredients: water for injections; tartrazine; glacial acetic acid - chlorhexidine acetate (0.1 %) with cetrimide (1 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

BAXTER Chlorhexidine 0.05% Cetrimide 0.5% AHF7979 solution Australia - English - Department of Health (Therapeutic Goods Administration)

baxter chlorhexidine 0.05% cetrimide 0.5% ahf7979 solution

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 0.5 mg/ml; cetrimide, quantity: 5 mg/ml - solution, irrigation - excipient ingredients: glacial acetic acid; water for injections; tartrazine - chlorhexidine acetate (0.05 %) with cetrimide (0.5 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

BAXTER 0.015 Chlorhexidine acetate & 0.15% cetrimide solution AHF7971/AHF7970/AHF7969 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.015 chlorhexidine acetate & 0.15% cetrimide solution ahf7971/ahf7970/ahf7969

baxter healthcare pty ltd - chlorhexidine acetate, quantity: 0.15 mg/ml; cetrimide, quantity: 1.5 mg/ml - solution, irrigation - excipient ingredients: water for injections; glacial acetic acid; tartrazine - chlorhexidine acetate (0.015 %) with cetrimide (0.15 %) antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

BAXTER WATER FOR INJECTIONS 1000mL injection BP bag AHB0304 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter water for injections 1000ml injection bp bag ahb0304

baxter healthcare pty ltd - water for injections, quantity: 1000 ml - injection, solution - excipient ingredients: water for injections - sterilised water for injections is employed as a vehicle for medicinal products when water is a suitable solvent for dissolving or diluting injectable therapeutic substances for parenteral administration.